PROF. Marie Ranson
"I hope our research can help steer decisions for effective personalised cancer treatments"
Taking cancer personally
"You've got cancer!" Not something any of us want to hear. But is it a potential killer version, or a relatively harmless lump that can be easily removed and forgotten about? Professor Marie Ranson is working on deciphering which tumours are the really dangerous, or metastatic, ones, based on their genetic markers. Determining the genetic changes seen in metastatic versus non-spreading cancer will allow a quick safety check of a tumour which can help doctors stratify risk and guide their treatment choices. Professor Ranson is also working to develop cell culture systems using cancer tissue to rapidly test how well cancer cells actually respond to a particular treatment. These systems could be used to help steer decisions for effective personalised treatments.
Professor Marie Ranson received her PhD from the University of Sydney (1990). After a post-doctoral Fellowship at the National Institutes of Health in Bethesda MD, USA she obtained a Research Fellowship and then a tenured teaching and research academic position in the School of Biological Sciences at the University of Wollongong. Marie was also recently appointed as the Illawarra Lead and executive member of the Cancer Institute NSW funded CONCERT Translational Cancer Research Centre. Her main area of expertise is in cancer biology and she contributes to several cancer drug discovery/development projects. She was a past recipient of the University of Wollongong Vice-Chancellor’s Award for Excellence in Research Supervision. Marie serves on a number of committees including the Federal Government’s Gene Technology Technical Advisory Committee.